Stockreport

Ironwood Pharmaceuticals, Inc.'s (IRWD) CEO Mark Mallon on Q2 2020 Results - Earnings Call Transcript [Seeking Alpha]

Ironwood Pharmaceuticals, Inc. - Class A  (IRWD) 
Last ironwood pharmaceuticals, inc. - class a earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.ironwoodpharma.com
PDF Ironwood Pharmaceuticals, Inc.(NASDAQ:IRWDCompany ParticipantsMeredith Kaya - Vice President, Investor Relations and Corporate CommunicationsMark Mallon - Chief Executiv [Read more]